• [1]
    Schweizer, H.P. (2001) Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol. Lett. 202, 17.
  • [2]
    McMurry, L.M., Oethinger, M., Levy, S.B. (1998) Triclosan targets lipid synthesis. Nature 394, 531532.
  • [3]
    Larkin, M. (1999) A close look at triclosan raises questions. Lancet 353, 1160.
  • [4]
    Bhargava, H.N., Leonard, P.A. (1996) Triclosan: applications and safety. Am. J. Infect. Control. 4, 209218.
  • [5]
    Chuanchuen, R., Beinlich, K., Hoand, T.T., Becher, A., Karkhoff-Schweizer, R.R., Schweizer, H. (2001) Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: Exposure of a susceptible mutant strain to triclosan selects nfx mutants overexpressing MexCD-OprJ. J. Antimicrob. Agents Chemother. 45, 428432.
  • [6]
    McMurry, L.M., Oethinger, M., Levy, S.B. (1998) Overexpression of marA, SoxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166, 305309.
  • [7]
    Levy, S.B. (2002) Antibacterial household products: cause for concern. Emerg. Infect. Dis. 7, 512515.
  • [8]
    Braoudaki, M., Hilton, A.C. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J. Clin. Microbiol., (2004), 42.
  • [9]
    Russell, A.D. (2002) Introduction of biocides into clinical practice and the impact on antibiotic resistant bacteria. J. Appl. Microbiol. Symp. Suppl. 92, 121S135S.
  • [10]
    Maillard, J.-Y. (2002) Bacterial target sites for biocide action. J. Appl. Microbiol. Symposium Suppl. 92, 16S27S.
  • [11]
    Tattawasart, U., Maillard, J.-Y., Furr, J.R., Russell, A.D. (1999) Development of resistance to chlorohexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J. Hosp. Infect. 42, 219229.
  • [12]
    Poole, K. (2002) Mechanisms of bacterial biocides and antibiotic resistance. J. Appl. Microbiol. Symposium Suppl. 92, 55S64S.
  • [13]
    Nikaido, H., Basina, M., Nguyen, V., Rosenberg, E. (1998) Muiltdrug efflux pumps AcrAB of Salmonella typhimurium excretes only those β-lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180, 46864692.
  • [14]
    Levy, S.B. (2002) Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. Symposium Suppl. 92, 65S71S.
  • [15]
    Eisen, J.A. (2001) Gastrogenomics. Nature 409, 463466.
  • [16]
    National Committee for Clinical Laboratory Standards. (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA.
  • [17]
    Hopkins, K.L., Hilton, A.C. (2001) Optimisation of ramdom amplification of polymorphic DNA analysis for molecular subtyping of Escherichia coli O157. Lett. Appl. Microbiol. 32, 126130.
  • [18]
    British Society for Antimicrobial Chemotherapy. (1991) Journal of Antimicrobial Chemotherapy, vol. 27, suppl. D. Guide to sensitivity testing, Academic Press, London, UK.
  • [19]
    Perna, N.T.Plunket, G. III Burland, V., Mau, B., Glasner, J.D., Rose, D.J., Mayhew, G.F., Evans, P.S., Gregor, J., Kirkpatrick, H.A., Posfai, G., Hackett, J., Klink, S., Boutin, A., Shao, Y., Miller, L., Grotbeck, E.J., Davis, N.W., Lim, A., Dimalanta, E.T., Potamousis, K.D., Apodaka, J., Anatharaman, T.S., Lin, J., Yen, G., Schwartz, D.C., Welch, R.A., Blattner, F.R. (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Lett. Nature 409, 529533.
  • [20]
    Whittam, T.S., Wachsmuth, I., Wilson, R. (1998) Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with haemorrhagic colitis and haemolytic ureamic syndrome. J. Infect. Dis. 157, 11241133.
  • [21]
    LeClerc, J.E., Li, B., Payne, W.L., Cebula, T.A. (1996) High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 12081211.
  • [22]
    Whittam, T.S., Reid, S.S., Selander, R.K. (1998) Mutators and long-term molecular evolution of pathogenic Escherichia coli O157:H7. Emerg. Infect. Dis. 4, 615617.